These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6960802)

  • 1. [Plasma protein changes in essential arterial hypertension: a new genetic marker for arterial hypertension?].
    Cloix JF; Devynck MA; Meyer P
    Ann Pediatr (Paris); 1982 Nov; 29(9):655-6. PubMed ID: 6960802
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma protein changes in essential hypertension: a new genetic marker of hypertension?].
    Cloix JF; Devynck MA; Meyer P
    Sem Hop; 1983 Apr; 59(15):1189-90. PubMed ID: 6306795
    [No Abstract]   [Full Text] [Related]  

  • 3. [Markers of essential arterial hypertension].
    Cambien F
    Sem Hop; 1983 May; 59(18):1427-8. PubMed ID: 6306830
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of disturbed balance between plasma proteins and tissue proteins in essential arterial hypertension].
    Sumenković N
    Srp Arh Celok Lek; 1975; 103(11):1011-5. PubMed ID: 1233772
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinicogenetic aspects of carbohydrate metabolism disorders and efficacy of their correction with moxonidine and metformine in patients with arterial hypertension].
    Kobalava ZhD; Tolkacheva VV; Ignat'ev IV; Glezer MG; Kuzin AI; Karpov IuA; Konradi AO; Zheleznykh EA
    Ter Arkh; 2005; 77(1):46-51. PubMed ID: 15759454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between inflammation and arterial stiffness in patients with essential hypertension.
    Kampus P; Muda P; Kals J; Ristimäe T; Fischer K; Teesalu R; Zilmer M
    Int J Cardiol; 2006 Sep; 112(1):46-51. PubMed ID: 16297996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Familial and nonfamilial forms of arterial hypertension].
    Bubnov IuI; Arabidze GG; Maksimova NV; Khalilov I; Kutsenko AI; Koshechkin VA
    Ter Arkh; 1993; 65(12):16-9. PubMed ID: 8146763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of arterial stiffness in offspring of families with essential hypertension.
    Yasmin ; Falzone R; Brown MJ
    Am J Hypertens; 2004 Apr; 17(4):292-8. PubMed ID: 15062881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in protein metabolism in arteriosclerosis patients].
    Junker L; Barleben H; Wagenknecht C; Jung K
    Z Gesamte Inn Med; 1990 Apr; 45(8):234-5. PubMed ID: 2378137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Population-genetic study of arterial hypertension].
    Bubnov IuI
    Ter Arkh; 1987; 59(1):45-7. PubMed ID: 3470968
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of essential hypertension with a microsatellite marker on chromosome 17.
    Cheung BM; Leung RY; Man YB; Wong LY; Lau CP
    J Hum Hypertens; 2005 May; 19(5):407-11. PubMed ID: 15716982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amino acid metabolism in patients with hypertension].
    Rybachuk IA; Denisiuk VI
    Vrach Delo; 1976 Jul; (7):73-6. PubMed ID: 997479
    [No Abstract]   [Full Text] [Related]  

  • 13. Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension.
    Simic DV; Mimic-Oka J; Pljesa-Ercegovac M; Savic-Radojevic A; Opacic M; Matic D; Ivanovic B; Simic T
    J Hum Hypertens; 2006 Feb; 20(2):149-55. PubMed ID: 16341053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered levels of erythrocyte calcium-binding proteins in essential hypertensives with genetic predisposition: correlation with ambulatory blood pressure.
    Hojo Y; Ebata H; Kawasaki K; Tsuruya Y; Ikeda U; Nishinaga M; Natsume T; Ishida H; Shimada K
    J Hypertens; 1994 Apr; 12(4):429-37. PubMed ID: 8064167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the plasminogen activator inhibitor-1 gene a candidate gene predisposing to hypertension? Results from a population-based study in Spain.
    Martínez-Calatrava MJ; González-Sánchez JL; Zabena C; Martínez-Larrad MT; Luque-Otero M; Serrano-Ríos M
    J Hypertens; 2007 Apr; 25(4):773-7. PubMed ID: 17351368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of calcitonin-receptor-like receptor gene in essential hypertension.
    Sano M; Kuroi N; Nakayama T; Sato N; Izumi Y; Soma M; Kokubun S
    Am J Hypertens; 2005 Mar; 18(3):403-8. PubMed ID: 15797661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension.
    Pietri P; Vyssoulis G; Vlachopoulos C; Zervoudaki A; Gialernios T; Aznaouridis K; Stefanadis C
    J Hypertens; 2006 Nov; 24(11):2231-8. PubMed ID: 17053545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein oxidation in mild essential hypertension.
    Caimi G; Mulè G; Hopps E; Carollo C; Lo Presti R
    Clin Hemorheol Microcirc; 2012; 50(3):193-5. PubMed ID: 22240348
    [No Abstract]   [Full Text] [Related]  

  • 19. [The influences of genetic and environmental factors on plasma plasminogen activator inhibitor-1 levels in patients with essential hypertension].
    Song Y; Xu W; Chen Y; Che L; Wang Q; Zhou X; Wu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec; 16(6):374-6. PubMed ID: 10581347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives].
    Vetter H; Zumkley H; Glänzer K; Witassek F; Wollnik S; Vetter W
    Schweiz Med Wochenschr; 1980 Dec; 110(50):1938-41. PubMed ID: 7010579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.